Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Awais Humayun

Clinical Cardiac Electrophysiology Davie, FL Medical Doctor

NPI 1346288768 CMS profile 333599

4801 S University Dr Ste 104, Ste 104, Davie, FL 33328

Open in the dashboard

General payments

$92,142

991 records reported · program years 2019–2025

Research payments

$25,090

Paid to them · 8 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$461,845 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Awais Humayun of Davie, FL is reported in the CMS Open Payments database as having received $92,142 across 991 general payments and $25,090 in research payments paid to them. Separately, studies naming them as principal investigator received $461,845 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 89th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,323 115
2025 Research $8,474 3
2024 General $29,730 134
2023 General $3,459 110
2023 Research $10,031 3
2022 General $4,632 114
2021 General $12,618 168
2020 General $10,448 158
2019 General $19,931 192
2019 Research $6,585 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Awais Humayun
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Awais Humayun were reported at $11,323. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Awais Humayun Clinical Cardiac Electrophysiology median Middle half National median
2019 $19,931 $2,361 $585–$8,260 $163
2020 $10,448 $993 $247–$4,351 $114
2021 $12,618 $1,185 $326–$4,739 $132
2022 $4,632 $2,073 $554–$6,789 $149
2023 $3,459 $2,568 $759–$8,159 $160
2024 $29,730 $2,557 $703–$7,403 $164
2025 $11,323 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $64,074 540 payments
  2. Medtronic, Inc. $11,310 151 payments
  3. Medtronic Vascular, Inc. $7,671 46 payments
  4. Biotronik Inc. $2,641 25 payments
  5. Boston Scientific Corporation $1,831 65 payments
  6. Atricure, Inc. $741 6 payments
  7. Impulse Dynamics (USA) Inc. $658 9 payments
  8. Pfizer Inc. $637 24 payments
  9. Janssen Pharmaceuticals, Inc $474 25 payments
  10. Cardiva Medical, Inc. $455 16 payments
  11. Other $1,652 84 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $33,877 55 payments
  2. Travel and Lodging $26,903 60 payments
  3. Food and Beverage $22,019 871 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,300 3 payments
  5. Education $43 2 payments
Products named General payments · program years 2019–2025
  1. AMPLATZER AMULET $31,433 49 payments
  2. Fortify Assura, Ellipse ICD $7,155 18 payments
  3. Arctic Front Ablation $6,607 20 payments
  4. Anthem CRT Pacemaker $5,544 18 payments
  5. Assurity Pacemaker $3,726 16 payments
  6. Accent Pacemaker $3,534 2 payments
  7. AVEIR Cardiac Rhythm Management $2,443 18 payments
  8. Arctic Front Ablation $1,683 23 payments
  9. Allure CRT Pacemaker $1,646 4 payments
  10. AVEIR Cardiac Rhythm Management $1,631 20 payments
  11. Other $22,987 819 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $18,505 6 payments
  2. Abbott Laboratories $6,585 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 22 drugs

Part D claims

1,470

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$453,247

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

40.5%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 334 $333,559
Xarelto Rivaroxaban Brand 76 $71,805
Entresto Sacubitril/Valsartan Brand 16 $21,226
Amiodarone Hcl Generic 239 $8,046
Dofetilide Generic 21 $5,239
Metoprolol Succinate Generic 229 $2,681
Flecainide Acetate Generic 63 $2,118
Mexiletine Hcl Generic 16 $1,499
Sotalol Sotalol Hcl Brand 70 $1,422
Midodrine Hcl Generic 17 $1,397

The 10 drugs with the highest cost, of 22 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$349,629

Medicare's payments for the services billed

Medicare patients

994

Average age 77

Services billed

4,982

510 women, 484 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 56%
Atrial fibrillation 55%
Chronic kidney disease 51%
Diabetes 49%
Heart failure 47%
Arthritis 47%
Depression 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
$114 334 —
Arcalyst
$57 — —
XARELTO
$40 76 —
PAXLOVID
$31 — —
CAMZYOS
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

999 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record